Latest Breaking News On - Hemanth nandigala - Page 1 : comparemela.com

How We Can Achieve Vaccine Internationalism – and Why We Need To

How We Can Achieve Vaccine Internationalism – and Why We Need To
thewire.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thewire.in Daily Mail and Mail on Sunday newspapers.

South africaEstado de pernambucoXolelwa mlumbi peterBenjamin blancoAnyang nyongoRogelio maytaRegla pardoGatell ramHemanth nandigalaCarla vizzottiGiorgio jacksonJustin trudeauNiki ashtonPinarayi vijayanVarsha gandikota nellutlaJorge arreaza

India s shortage-hit Covid-19 inoculation drive may get lifeline from Russia s Sputnik V vaccine

India s shortage-hit Covid-19 inoculation drive may get lifeline from Russia s Sputnik V vaccine
straitstimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from straitstimes.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshSouth koreaHemanth nandigalaNikolay kudashevKiril dmitrievStelis biopharmaSerum institute of india astrazenecaRussian direct investment fundHyderabad based dr reddyBharat biotechSerum instituteHetero biopharmaGland pharmaVirchow biotechPanacea biotecShilpa biologicals

Biden Has the Power to Vaccinate the World

Biden Has the Power to Vaccinate the World Chelsea Clinton © Niharika Kulkarni / Reuters As the number of COVID-19 cases in the United States falls and the economy recovers, India is experiencing a deadly resurgence of the coronavirus, with more than 370,000 new infections and 3,500 deaths every day. Hospitals in Delhi are running out of oxygen, and crematoria have used all of their firewood. Experts predict that the surge is nowhere near its peak. The Indian crisis is precipitating a global one. One-third of the world currently relies on vaccine exports from a single company in India. However, to meet the overwhelming domestic need, India banned vaccine exports, which means that countries in sub-Saharan Africa are now scrambling for vaccines leaving their population more vulnerable to resurgences of the virus. Ayoade Alakija, a co-chair of the African Vaccine Delivery Alliance, told the

United statesUnited kingdomSouth africaUnited arab emiratesAndhra pradeshEstado de pernambucoDonald trumpFranklind rooseveltBill gatesInstituto butantanJoe bidenHemanth nandigalaAbu dhabiAyoade alakijaWorld health organizationMelinda gates foundation

Covid-19 vaccines: India to face a problem of plenty

Image: Alamy India, the world’s largest vaccine producer, is heading for an unusual problem of plenty with Covid-19 vaccines. At least 20 different Covid-19 vaccines are in various stages of development in the country while vaccine manufacturers have built a massive annual capacity exceeding 3 billion doses. Top industry officials predict that the prices of the vaccines are likely to crash in the next few months. “Post June, the Covid-19 vaccine market is going to be like a sanitiser market. There will be too many vaccines available, and nobody would need to wait in a queue. It is going to be a problem of plenty,” says Dr Hemanth Nandigala, managing director of Virchow Biotech, a vaccine maker.

Andhra pradeshUnited statesIndian immunologicalsHemanth nandigalaShantha biotechnicsZydus cadilaWashington university school of medicineWorld national biopharma missionRussian direct investment fundUniversity of wisconsinBiotechnology industry research assistance councilThomas jefferson university of philadelphiaVaccines ltdVirchow biotechBharat biotechPanacea biotec

Hyderabad, the new vaccine capital of India

Hyderabad, the new vaccine capital of India Apart from Covaxin and Sputnik V, companies based in the city are also involved in developing or manufacturing several other Covid-19 vaccines. Jan 23, 2021 When a senior technical team from Russia’s health ministry descended on Hyderabad in November 2020, nobody knew that it was breaking an emerging oligopoly in the Indian market, quietly but decisively. The manufacturing of the Covid-19 vaccine wasn’t meant to be restricted to a few. After auditing several facilities across the country, the Russian team chose three companies from Hyderabad, to undertake clinical trials for its Covid-19 vaccine, Sputnik V, in India and contract-manufacture the vaccine Dr Reddy’s Laboratories (DRL), Hetero Biopharma, and Virchow Biotech.

Andhra pradeshUnited statesHemanth nandigalaAurobindo pharmaRussian ministry of healthNational institute of virologyHyderabad rajiv gandhi international airportIndian council of medical researchWashington university school of medicineBharat biotech international ltdWorld national biopharma missionRussian direct investment fundUniversity of wisconsinGamaleya research institute of epidemiologyBiotechnology industry research assistance councilThomas jefferson university of philadelphia